E
Orchestra BioMed Holdings, Inc. OBIO
$2.60 $0.051.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -21.17% -39.31% -26.03% -15.85% -32.66%
Total Depreciation and Amortization 9.46% 12.16% 16.67% 7.04% 1.37%
Total Amortization of Deferred Charges -- -- 933.33% -- --
Total Other Non-Cash Items 27.46% 42.25% 105.04% -1.08% 215.23%
Change in Net Operating Assets -88.34% 46.02% -1,075.00% -204.24% 401.80%
Cash from Operations -52.14% -26.70% -23.36% -33.24% 2.71%
Capital Expenditure 68.22% -1,300.00% -3,633.33% -257.89% -296.30%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 55.64% 123.39% -109.19% -95.18% 29.29%
Cash from Investing 56.91% 121.79% -111.32% -95.70% 28.41%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -100.00% 405.56% -66.67% 375,775.00% 98.84%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -350.29% -1,744.44% 230.39% 375,775.00% 98.84%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 3.08% 45.92% -129.13% -29.11% 117.02%